The objective of this study was to determine whether different isolates of Babesia microti could be distinguished from morphologically similar isolates of B. gibsoni by using a ribosomal DNA (rDNA) probe. A Babesia-specific rDNA probe was obtained by polymerase chain reaction amplification of sequences from B. microti DNA using universal primers directed against highly conserved portions of the eukaryotic 16S-like rRNA gene. The chemiluminescent rDNA probe hybridized to Southern blots of restriction endonucleasedigested DNA preparations of different isolates of B. gibsoni from infected dogs and B. microti from infected humans and white-footed mice. Restriction fragment length polymorphisms served to differentiate these species. Although the hybridization patterns seen with DNAs from six B. microti isolates did not vary, those of the five B. gibsoni isolates did indicate genotypic variation. We concluded that isolates of B. microti and B. gibsoni can be differentiated on the basis of restriction fragment length polymorphism detected with a chemiluminescent rDNA probe.
Babesia species are intraerythrocytic, tick-transmitted protozoal parasites that infect a variety of mammals, both wild and domestic. Severe, often fatal cases of human babesiosis due to infection with bovine babesial parasites have been reported in Europe (12, 43) . In the United States, human babesial infections have been associated primarily with Babesia microti in New York and New England, where the parasite is transmitted from white-footed mice (Peromyscus leucopus) to humans by Ixodes dammini ticks (33, 39, 40) . Serological surveys in Cape Cod and Boston, Mass. (31) , and Shelter Island, N.Y. (15) , have shown that 3.7 to 6.9% of the healthy individuals tested were seropositive for B. microti antibodies and hence had been exposed to the parasite. Increasing numbers of clinical and asymptomatic cases of human babesiosis, including many outside of the New England area, are being reported (5, 6, 12, 16, 18, 21, 32, 38, 41) .
Despite the importance of babesial parasites of humans and domestic animals, little research has been directed towards their characterization. Identification of babesial species is based mainly on morphology, particularly size, and host specificity (22) . Babesia species are classified as small (1.5 to 2.5 ,um) or large (3 to 5 ,um); however, within these groups parasites from different hosts are often markedly similar in morphology. The generalization that Babesia species are strictly host specific, traditionally considered to be a clue for species designation, is no longer tenable since the discovery that parasites such as B. microti may infect not only a variety of small terrestial mammals (4, 13, 37, 44) but also a variety of subhuman primates (24, 34) and humans. B.
div,ergens has similarly been found to infect rats (28) , gerbils (26) , and humans (12) , as well as its main bovine host.
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Because the host range for these and other Babesia species is probably even wider than is presently recognized, diagnosis of babesial species infecting atypical hosts requires improved methods for parasite identification.
The present study sought to differentiate between two small babesial parasites of clinical significance, B. microti and B. gibsoni. B. gibsoni is a pathogen of dogs in Asia and Egypt which has been identified in the United States (2, 11) . Human babesiosis and canine babesiosis exhibit similar clinical manifestations, predominantly fever, anorexia, malaise, and anemia (11, 14, 18, 43) . B. microti and B. gibsoni cannot be reliably distinguished on the basis of light microscopic examination of Giemsa-stained blood smears, and they show considerable antigenic cross-reactivity in the indirect fluorescent-antibody test (42) ; these are the primary methods for the diagnosis of babesiosis (8) (20) and centrifuged at 16 ,000 x g in 0.5-ml microcentrifuge tubes. The pellets were washed three times in TE, taking care to remove the erythrocyte ghosts after each washing. (27) . To generate a B. microti-specific rDNA probe, PCR amplification of one of the plasmid clones was performed, as described above, by using primers A and C. The amplification product was labeled and used for hybridization as described below.
DNA preparation. Blood was collected from infected animals when >20% of the erythrocytes contained parasites.
Plasma and leukocytes were removed from the blood after centrifugation (400 x g, 10 min, 4°C), and the erythrocytes were washed once in cold, sterile phosphate-buffered saline. Pelleted erythrocytes were suspended in 10 volumes of medium M199 with Earle's balanced salt solution (GIBCO Laboratories, Grand Island, N.Y.) with 100 U of penicillin per ml and 100 ,ug of streptomycin sulfate per ml. Twentymilliliter aliquots of suspended cells were incubated in 75-cm2 tissue culture flasks at 37°C in 5% C02-air with 95% humidity to allow merozoites to accumulate in the medium. After 24 h, the cultures were resuspended and erythrocytes, many containing parasites, were pelleted by centrifugation at 700 x g for 10 min at 4°C (P1). The supernatant was removed and centrifuged (1,000 x g, 10 min, 4°C). Merozoites were obtained for DNA isolation by centrifugation (16,000 x g, 10 min, 4°C) of the resultant supernatant (P3). Control mammalian cell DNA was prepared from leukocytes that were separated from uninfected canine, human, and hamster blood by differential centrifugation (400 x g, 20 min, 4°C) on Ficoll-Paque (Pharmacia LKB Biotechnology, Piscataway, N.J.) gradients. DNA was prepared from Babesia-infected erythrocytes (P1) and leukocytes as described previously for theilerial piroplasms and lymphoblastoid cells (10 Detection of B. microti and B. gibsoni RFLP with rDNA probe. Since restriction digests of the different DNAs were not sufficiently distinct to serve as a reliable method for species discrimination, a Babesia-specific rDNA probe was evaluated by hybridization to Southern blots of restriction enzyme-digested babesial DNAs. Despite having been generated from B. microti, the rDNA sequence probe hybridized to DNAs from all of the babesial isolates and made possible species differentiation of the isolates on the basis of the resultant RFLPs. Unless otherwise indicated, there were no differences between the hybridization patterns seen when the same blot was subjected to low-or high-stringency wash conditions after hybridization. Figure 2 shows Fig. 2 Fig. 3 , were due to hybridization to a 7.7-kb fragment in DNAs from all of the B. gibsoni isolates (seen only after the 2x SSC washing) and a 0.7-kb fragment in all of the B. microti DNAs.
Results obtained with hybridization of the probe to Southern blots of EcoRI-digested DNA preparations are shown in Fig. 4 Similarly, hybridization patterns produced with Sau3A-digested DNAs from the B. gibsoni isolates were distinctly different from those produced by the B. microti isolates (data not shown). The rDNA probe identified sequences in 1.6-, 1.0-, and 0.9-kb fragments in Sau3A-digested DNAs of the five B. gibsoni isolates and in a 1.0-kb fragment in DNAs of the human (2Bm and 3Bm) and rodent (5Bm and 6Bm) B. microti isolates tested. Some variation between B. gibsoni isolates was demonstrated, with hybridization occurring to additional fragments of 1.7 and 1.4 kb in Sau3A-digested DNAs from isolates lBg and 7Bg.
DISCUSSION
Electrophoretic separation of restriction endonuclease digests of merozoite DNA showed that B. microti isolates from rodents and humans had similar restriction patterns and that these patterns differed from those produced by DNA from B. gibsoni isolated from dogs. These differences were more clearly and consistently demonstrated by Southern blot   FIG. 4 . Hybridization of EcoRI-digested leukocyte and babesial merozoite DNAs with a chemiluminescent rDNA probe. Lanes: 1, canine leukocytes; 2 to 6, B. gibsoni isolates 4Bg, 2Bg, 3Bg, 7Bg, and lBg, respectively; 7, blank; 8, human leukocytes; 9, hamster leukocytes; 10, blank; 11 to 14, B. microti isolates 3Bm, 5Bm, 6Bm, and 2Bm, respectively. Molecular sizes are indicated in kilobases on the left. analysis using a probe which was produced by PCR amplification of a 16S-like rDNA sequence from B. microti DNA. The probe hybridized to DNAs from isolates of both species, and the RFLPs demonstrated distinct genotypic differences between isolates of B. microti and B. gibsoni.
Although the predominant hybridization bands were consistent among the various B. gibsoni DNAs, there was some minor variation between isolates. The hybridization patterns seen with 2Bg, 3Bg, and 4Bg were the same; however, differences between these isolates and the lBg and 7Bg isolates were apparent with HaeIII-, EcoRI-, and Sau3A-digested DNAs. These results are not surprising, since the 3Bg and 4Bg isolates were obtained from dogs that were experimentally infected with blood from dog 2Bg, whereas dogs lBg and 7Bg received blood from two different, naturally infected dogs. Genotypic differences between isolates and subpopulations within other Babesia (7, 17, 19) and closely related Theileria species (1, 9, 10) have been demonstrated by using genomic DNA probes. However, this is the first report of the successful use of an rDNA sequence probe to distinguish different isolates within the same species and between Babesia species on the basis of RFLPs.
In comparison with the B. gibsoni isolates, the hybridiza- (25) and that some of these are more infective for humans than the ubiquitous rodent strain(s). The B. microti isolates examined in the present study were derived from clinically infected humans or P. leucopus mice that were trapped near the homes of infected humans; all of the isolates used may therefore be representative of a predominant parasite strain or one that is most pathogenic for humans.
Human babesiosis is one of several zoonotic tick-borne diseases of increasing importance in North America (12, 29) . Cases of human babesiosis in Europe typically involve another species (B. divergens) infecting splenectomized individuals, but in the United States spleen-intact patients may be affected (12, 18, 43) . In addition, advanced age and infection with the human immunodeficiency virus appear to predispose patients to clinical babesiosis (3, 33, 43) . These factors, combined with the increasing number of cases of human babesiosis, indicate a need for a better understanding of small babesial parasites and their host range.
The epidemiology of human B. microti infections has been most extensively studied in the northeastern United States, where the parasite shares common reservoir hosts and a natural tick vector, L dammini, with Borrelia burgdorferi, the causative agent of Lyme disease (40) . In other parts of the country, little is known about the epidemiology of small Babesia species, including the primary vector species, susceptibility of humans to these parasites, or occurrence of coinfections with other tick-transmitted disease agents, such as B. burgdorferi or Ehrlichia spp. Rodent-derived B. microti has been incriminated as the cause of human babesiosis in California (5, 6, 36) ; however, these cases could also have resulted from infection with another small babesial parasite, such as B. gibsoni. Multiple cases of canine B. gibsoni infections have been reported in California (11) , and an infected dog was identified in Connecticut (2) . Distribution of this parasite is undoubtedly wider than these reports indicate, because infected dogs probably remain asymptomatic carriers of B. gibsoni for many years and they are likely to accompany their owners when they travel or move to different parts of the country. In addition to the natural foci of B. gibsoni infection which have been reported, it is estimated that hundreds of dogs a year are imported to the United States from areas in Asia where B. gibsoni is endemic, and many of these are potential parasite carriers (14) .
Both human babesiosis and canine babesiosis are frequently misdiagnosed, particularly in areas where the causative organisms are not endemic, when autoanalyzers are used in hematology laboratories for blood cell differential counts or when medical personnel are not familiar with these parasites (6, 11) . B. microti and B. gibsoni are morphologically indistinguishable on stained thin blood smears; both appear as small pleomorphic, intraerythrocytic protozoa that are usually round, oval, or pear shaped, with occasional characteristic tetrad or Maltese cross forms. Serologic results of indirect fluorescent-antibody tests, which are commonly used for diagnosis of babesial infections, can also be confusing because there is considerable antigenic crossreactivity between B. microti and B. gibsoni. For example, some Babesia-infected humans and dogs with reciprocal titers of 2,560 to 40,960 to B. microti and B. gibsoni antigens, respectively, showed reciprocal titers of 320 to 2,560 to the heterologous antigen (42) . The other method used to determine whether human babesiosis is due to B. microti is to inoculate blood from infected patients into hamsters (4 Analysis of the rDNA sequence amplified in the present study showed 75% homology between the probe sequence and the published sequences of the first 550 bp from the 5' end of human and rodent 16S-like rRNAs. This explains the limited hybridization of the probe to Southern blots of mammalian host cell DNAs. Previous examinations of endonuclease-digested DNAs from other babesial isolates and Theileria parasites (10) have shown that host cell contamination can obscure the distinct banding pattern which is otherwise apparent on ethidium bromide-stained gels of electrophoretically separated restriction fragments. Host cell DNA contamination in the preparations used in the present study was apparently minimal, judging from the clarity of the restriction patterns and the limited hybridization of the probe to DNAs of the different babesial isolates. This host cell contamination did not impede our ability to differentiate babesial isolates on the basis of RFLPs. However, in the development of Babesia speciesspecific probes for future studies, sequences which lack homology to mammalian cell rRNA can be selected. Identification of B. microti and B. gibsoni sequences will be useful for generation of more specific oligonucleotide primers that can be utilized with PCR for detection of parasites in the blood of infected humans and dogs or in the tissues of infected ticks.
